PEDIATRIC NEPHROLOGY, vol.36, no.5, pp.1195-1205, 2021 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
Complement, CKD stage 5, Children, C3 glomerulopathy, Predictors, DENSE DEPOSIT DISEASE, MYCOPHENOLATE-MOFETIL, MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, POSTINFECTIOUS GLOMERULONEPHRITIS, ECULIZUMAB, EXPERIENCE
Bursa Uludag University Affiliated:
Background C3 glomerulopathy (C3G) is characterized by heterogeneous clinical presentation, outcome, and predominant C3 accumulation in glomeruli without significant IgG. There is scarce outcome data regarding childhood C3G. We describe clinical and pathological features, treatment and outcomes, and risk factors for progression to chronic kidney disease stage 5 (CKD5) in the largest pediatric series with biopsy-proven C3G.